Prefatory Matters
IP Policy Forum: Drug Development - Translating Basic Research Into New Medicines - and This Issue of IPLR
Tommy Thompson
IP Policy Forum: Forward-Looking View of Healthcare Innovation, From a Leading Life Science Venture Capitalist
G. Steven Burrill
IP Policy Forum: The Increasing Importance of Biologics-Based Drugs in Pharmaceutical Pipelines
David Meininger
IP Policy Forum: Need for New IP Approaches to Facilitate Collaborative (Academic-Industrial) Drug Development
Garret A. Fitzgerald
IP Policy Forum: The Future of Clinical Trials: More Transparency and Pharmacogenomics
Harsha K. Rajasimha
IP Policy Forum: Implications of Genomics Advances for Drug Discovery, Clinical Therapies, & Rare Disease Research
John R. Raymond
IP Policy Forum: Intellectual Property Rights (IPR) In Collaborative Drug Development in the EU: Helping a European Public-Private Partnership Deliver - The Need for a Flexible Approach to IPR
Hugh Laverty and Magali Poinot
Nies Memorial Lecture
Diagnostic Patents at the Supreme Court
Arti K. Rai
Intellectual Property Policy Forum Articles
Ancillary Orders of Compulsory Licensing and Their Compatibility with the TRIPS Agreement
Richard Li-dar Wang
Intellectual Property Policy Forum Comments
International Intellectual Property Scholars Series
Trademarks Under the North American Free Trade Agreement (NAFTA), with References to the Current Mexican Law
Roberto Rosas